
Frontiers in Immunology, Год журнала: 2024, Номер 15
Опубликована: Июль 25, 2024
Current vaccines against COVID-19 elicit immune responses that are overall strong but wane rapidly. As a consequence, the necessary booster shots have contributed to vaccine fatigue. Hence, would provide lasting protection needed, still unavailable. Cytomegaloviruses (CMVs) and uniquely responses. Used as vectors, they may be attractive tools obviate need for boosters. Therefore, we tested murine CMV (MCMV) vector in relevant preclinical models of immunization challenge. We previously developed recombinant MCMV expressing spike protein ancestral SARS-CoV-2 (MCMV
Язык: Английский